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rostate Cancer is the most common malignancy 
in Nigerian males and also in elderly males 
1,2Pworldwide . It is the second cause of cancer 
3death following lung cancer in men .It is rare under the 
age of 40 and its incidence has been shown to increase 
4exponentially with age .The life time risk of Prostate 
Cancer is approximately 16%; but the lifetime risk of 
5Prostate Cancer Death is only 3.4% .
Previously, Prostate cancer was thought to be a disease 
rare in blacks owing to the fact that not so much was 
known of the disease. The risk of prostate cancer 
among Black- Africans has a 30-50 times difference 
while native Japanese and Chinese men are at lowest 
3risk of the spectrums . In Nigeria, a hospital based 
study showed incidence of 127/100,000 cases with a 
6national population risk of 2% . This was compared to 
its low incidence in previous years owing to gross 
underestimation of the disease. 
The incidence of prostate cancer in developing 
countries is at a surge with increased use of screening 
techniques using digital rectal examination(DRE) and 
serum concentration of prostate specific antigen (PSA). 
The screening techniques have led to more diagnosis of 




Prostate cancer has become a global health challenge because of its rising morbidity and mortality in males. It is the 
second cause of cancer death following lung cancer in men. It is rare under the age of 40 and its incidence has been 
shown to increase exponentially with age. Previously, Prostate cancer was thought to be a disease rare in blacks 
owing to the fact that not so much was known of the disease. 
AIM AND OBJECTIVES: The objective of the study was to review the prevalence, pattern of presentation and 
clinic-pathologic findings of prostate cancer in the Department of Radiotherapy, Lagos University Teaching Hospital 
(LUTH), between January 2001 to December 2010 in comparison to previous and recent studies globally.
METHODOLOGY: Data collection for all patients histologically diagnosed with Prostate cancer at the 
Department of Radiotherapy, LUTH, from 1st of January 2001 to 31st of December 2010 was done. 
Results: A total of 144 cases with histologically confirmed Prostate cancer seen during the ten year study were 
analysed. The highest frequency was seen in the year 2010 with 34 cases. The age range was 41 to 81years with a 
mean of 66.19 ±7.30years. Adenocarcinoma was the commonest histological type with 98.6%. 9(6.3%) patients had 
a positive family history of prostate cancer out of which 3(33.3%) had their brother affected the malignancy. 
51(35.4%) patients presented with stage IV disease. 18(12.5%) patients had a Gleason's score of 6, 10(6.9%) patients 
had a Gleason's score of 7 and 2(1.4%) patients had a Gleason's score of 10. The most common presenting 
complaints were bone pains seen in 51(35.4%) patients, frequent night urine and difficulty with micturition seen in 
50(34.7%) and 42(29.2%) patients respectively.
CONCLUSION: This study showed that prostate cancer is not as rare as it used to be. Reasons attributed to its 
rarity then were lack of awareness, poor screening facilities and poor diagnosing technique. 
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was a farmer (Table 2.0). Majority of the patients 
122(84.7%) were Christians and 22(15.3%) were 
Muslims. 82(56.9%) patients were Yorubas by tribe 
while 33(22.9%) were Igbos and 29(20.1%) were from 
the minority, none was from the northern part of 
Nigeria. 79(54.9%) patients had tertiary level of 
education, while 9(6.3%) and 5(3.9%) had secondary 
and no formal level of education respectively (Table 
2.0). 25(17.4%) of the patient consume alcohol while 
24(16.7%) had a smoking history. Majority of the 
patient 109(72.2%) neither smoke nor consume alcohol 
(Table 2.0). 9(6.3%) patient had a positive family history 
of prostate cancer in which 3(33.3%) had their brothers 
affected while the others 6(66.7%) had a close relative 
eg Uncle affected by the disease. 51(35.4%) patients 
presented with stage IV disease, 9(6.3%) with stage III 
and 15(10.4%) had stage II disease. 69(47.9%) patients 
had no record of their staging at presentation (Table 
3.0).
The most common histology was adenocarcinoma with 
142 (98.6%) and 2(1.4%) had small cell carcinoma (Table 
4.0).
The Gleason's score ranges from 2-10 and the mean 
score was 6.04±1.98. 18(12.5%) patients had a Gleason's 
score of 6 while 3(2.1%) patients had a Gleason score of 
2, it was not recorded in 61.8% of patients (Table 5.0). 
26(18 .1%)  pat ients  had anaplas t ic/poor ly  
differentiated adenocarcinoma and 8(5.6%) had well 
differentiated adenocarcinoma. 104(72.2%) had no 
record of their histologic grade (Figure 2.0). The most 
common presenting complaints were bone pain 
51(35.4%), frequent night urine 50(34.7%), difficulty 
with micturition 42(29.2%), weak urine flow 22(15.3%), 
burning painful urine 22(15.3%), erectile dysfunction 
6(4.2%), painful ejaculation 1(0.7%) and hematuria 
10(6.9%) (Table 6.0).
However, despite the increased use of screening 
techniques late presentation still accounts for increased 
morbidity and mortality rate of this disease and is still a 
dilemma as it is prevalent in developing countries. In 
Nigeria, a study showed that approximately 80% of 
patients present late with approximately 60% 
1presenting with metastasis . This has been attributed to 
the fact that most often times the diagnosis is missed 
and those who are diagnosed fail to come back for 
treatment due to socio-cultural reasons. 
The histology of prostate cancer could be favourable or 
unfavourable. A study showed that favourable 
3histological types (adenocarcinoma) are commoner . 
Patients with well differentiated types and localised 
disease have excellent prognosis but owing to 
latepresentation with metastasis this tends to increase 
morbidity and mortality rates.
The aim of this study was to report the prevalence, 
pattern of presentation and clinico-pathological 
findings seen in patients receiving treatment at LUTH 
which as a tertiary referral centre provides care for Uro-
oncology cases.
MATERIAL AND METHODS
This is a retrospective review study of all patients with 
histologically confirmed Prostate Cancer cases in the 
medical records register and seen in the Department of 
Radiotherapy, LUTH, Lagos State between 1st of 
January 2001 and 31st of December 2010.The data for 
this research was obtained from the case notes of the 
patients. All possible information including patients' 
age, clinical presentation, Gleason's score, histology 
and stage were evaluated.
Statistical analysis was done using the Statistical 
17Package for the Social Sciences version .Analysed data 
is presented in the form of frequency tables, charts and 
cross tabulations.
Ethical approval was obtained from the Ethical and 
Research committee of LUTH, Lagos State where the 
study was done. 
RESULTS
A total of one hundred and forty four cases met the 
inclusion criteria for the study and were analysed. 
Patients were referred from all over Nigeria to the 
Radiotherapy department for treatment (Table 1.0).The 
age range was 41 to 81years with a mean of 66.19 
±7.30years. Sixty-four (44.4%) patients were between 
the age ranges of 61-70years while one (0.7%) was in the 
age group of 41-50years (Figure 1.0).  One hundred and 
thirty-seven (95.1%) patients were married while four 
(2.8%) were widowed. 44(30.6%) patients were civil 
servants both retired and non-retired, while 1(0.7%) 
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TABLES
Table 1.0: The number of Prostate cancer cases seen in 
the Department per year (2001-2010).
Table 2.0: The Socio-demographic characteristics of 
patients with Prostate cancer presenting in LUTH 
from 2001 to 2010.
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Table 6.0: Frequency distribution of presenting 
complaints.
Table 3.0: The Distribution of stages of the disease. 
Table 4.0: Frequency Distribution of type of 
Histological diagnosis of Prostate cancer among 
patients in LUTH (2001-2010). 
Table 5.0: Frequency distribution of Gleason's score.













































































Not recorded 89 61.8
Total 144 100.0
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CHARTS
Figure 1.0: Age distribution of the 144 cases of Prostate cancer.
Figure 2.0: The distribution of histologic grade.
with incidence of 16.5%, 9.2%, 7.13% and 6.15% of all 
7male cancers respectively . These results are contrary to 
previous perception on the rarity of the disease in 
Africa. The lowest number of cases were 9(6.3%), 
5(3.5%) and 7(4.9%) seen in 2002, 2005 and 2007 
respectively. Low number of cases seen during this 
period may be due to lack of radiotherapy machine or 
machine break down or facility short down during 
strike action of health workers. It was evident that 
several patients treated during this period had 
radiotherapy at nearby facilities and still came back to 
continue treatment at the clinic.
DISCUSSION
The one hundred and forty-four prostate cancer 
patients analysed during the study period represented 
3.1% of malignancies seen within the study period. It 
accounted for 12.1% of all male cancers seen over this 
period. The highest number of patients recorded was 
34(23.6%) in 2010. The study showed arise in incidence 
of Carcinoma of the Prostate, this indicates that despite 
the paucity of screening programs in Nigeria, the 
number of prostate cancer casesis still on the 
1increase .The incidence in this study is comparable to 
other studies from Kano, Zaria, Benin and Maiduguri 
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1, 20-23parts of the country .Small cell carcinoma of the 
prostate is rare accounting for less than 1% of prostate 
cancer4. We recorded 2 (1.4%) cases of small cell 
carcinoma of theprostate. Other studies done in 
Nigeria also showed low incidence of small cell 
carcinoma while those in Ibadan had no record of small 
cell carcinoma1.The prognosis of small cell carcinoma 
is poorthis is evident in this study. 1 of the 2 patients 
who had small cell carcinoma had metastatic disease. 
Other histological variants though rare seen in the 
South-south and South-western part of the country 
w e r e  s q u a m o u s  c e l l  c a r c i n o m a  a n d  
21,24adenosquamous . 
Most often early stages of Prostate cancer is 
asymptomatic, patients usually present with 
symptoms of frequent night urine, dysuria, erectile 
dysfunction, haematuria, bloody semen and bone pain 
in late or advanced stages. The commonest complaints 
were those of bone pain 51(35.4%) closely followed by 
obstructive and irritative symptoms which includes 
frequent night urine 50(34.7%), difficulty with 
micturition 42(29.2%), weak interrupted urine flow 
22(15.3%), burning painful urine 22(15.3%), painful 
ejaculation 1(0.7%), bloody urine 10(6.9%). Ahmed et al 
in their study reported that 54(25%) of their study 
population wereAsymptomatic,126(58%) had 
irritative symptoms, 13(6%) Obstructive symptoms 
25while 23(11%) Bone pain (deposits) . Bone pain is a 
common symptom of patients with bone metastasis. 
Majority of the patients seen in the clinic presented in 
late stages and were referred for Radiotherapy.
Late presentation of patients has been reported in many 
studies conducted in the country which leads to 
unfavourable outcome. The delay in presentation is 
attributed to poverty and ignorance on the part of the 
patient, lack of adequate treatment facilities and 
incompetence of some primary physicians in 
suspecting the disease and effecting early referral.
The stage, grade and histology is considered the most 
important prognostic factor in prostate cancer, other 
factors includes PSA level, patient's age and 
comorbidities.  Majority of patients presented with 
adenocarcinoma (98.6%) and had poorly differentiated 
carcinoma accounting for 18.1%. 104 patients had no 
record of their histologic grade. 51 patients had stage IV 
disease. PSA evaluation was not routinely done in the 
early part of the study as there were few skilled centres 
for doing the investigation. Some patients had been 
commenced on hormonal therapy for years before 
presenting to the clinic with advanced disease and had 
no record of previous PSA values. The Gleason score 
showed a predominance of scores 6 and 7 (moderately 
The mean age of Prostate cancer patients seen in 
Radiotherapy department was 66.19 ±7.30years and is 
1, 8-12comparable with what was found in earlier studies . 
In South-west Nigeria a study done by Ogunbiyi et al 
showed a median age of 67.5 years (variance 5.6), and 
1mean age 71.4 years (variance 14.3) . Mean ages of 70 
and 67.1years where recorded in Eastern and Northern 
12, 13Nigeria respectively . Heavy/long-term smoking is 
associated with an 11–22% increase in risk of prostate 
cancer, and current smokers have a 14% increased risk 
of dying of prostate cancer, with a risk increase of 
24–30% for those with the highest exposures, according 
14to a meta-analysis .The social habits of tobacco and 
alcohol consumption which was implicated in some 
studies was not specified in majority of patient case 
files. There is no association between alcohol 
15, 16consumption and prostate cancer risk  . International 
Agency for Research on Cancer (IARC) does not 
currently classify smoking as a cause of prostate 
17cancer .
A history of prostate cancer in a first-degree relative 
18increases risk of the disease by 120–150% . The risk for 
men with an affected father is increased by 112–140%, 
while those with an affected brother have a 187–230% 
18risk increase . In this study 9(6.3%) patients had a 
family history of prostate cancer and 3 of the patients 
had the disease in their brother. Previous studies reveal 
that the incidence of prostate cancer is hereditary in less 
4, 19than 5% of cases .
The distribution of patients according to geographical 
region indicated that the highest number of patients 
seen were from the southern part of the country, with 
the northern region accounting for a lower incidence. 
This may not be a true representation as the patients 
may have been referred to other radiotherapy centres 
closer to them. The prevalence rate seen in our study 
done in South West Nigeria is similar to that found in 
Northern and South Eastern part of the country as 
7reported by a study done by Akinremi et al .  This has 
shown that there is no ethnic variation in the 
prevalence of Prostate cancer in Nigeria which may be 
due to racial homogeneity of the country.
The majority of patients reviewed were Civil servants 
(both serving and retired) by occupation. This may not 
be due to occupational hazard they are exposed to at 
work but may be attributed to their literacy status 
(educational status) which has influenced their level of 
awareness and thus their decision to present for 
treatment. 
Histologically, adenocarcinoma was the commonest 
cell type 142(98.6%) found in this study. Several studies 
have shown that adenocarcinoma is prevalent in other 
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differentiated), patients with higher Gleason scores 
have more aggressive disease and tend to have worse 
prognosis than those with well differentiated 
25,26disease . 
CONCLUSION
The burden of Prostate cancer is a global challenge 
because of its increasing rate of morbidity and 
mortality. The prevalence was seen to have increased 
over the years with majority of the patients presenting 
in late stages. Despite the advances made in trying to 
combat the disease with the use of screening modalities 
a greater number of patients still present in late stages.
The disease has also been linked to race, familial 
association and genetic factors. However in this study 
there was no strong link with familial association 
which could be attributed to patient's unwillingness to 
disclose such information or not even knowing the 
cause of death of their relatives.
Major Prognostic factors in this study were stage at 
presentation and histological type.  Inadequate staging 
of the disease is still a challenge as several patients did 
not have a Gleason score, this is a significant prognostic 
index. Late presentation, irregular follow ups and 
poverty contributed to the poor outcome seen in most 
cases. Late presentation is still a dilemma in developing 
countries and the need for a collaborative effort is 
imperative.
RECOMMENDATION
There is a need to collate figures and improve 
education and knowledge. Gleason scoring should be 
mandatory for all patients. Social workers, religious 
leaders and the community should be involved in 
patient care, to help reduce the rate at which patients 
are lost to follow up. They should be encouraged to 
help to improve advocacy and screening of prostate 
cancer.
The government should ensure funding of quality 
controlled population based screening programmes in 
all geopolitical zones in the country which will ensure 
that men above the age of 50years should have yearly 
PSA evaluation as a government policy and at 
subsidized rates or no cost to the individuals.
LIMITATIONS
It was a retrospective study and some case notes were 
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supplied in the case notes for analysis such PSA values. 
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